Skip to Main content Skip to Navigation
Journal articles

Male Infertility and Genetic screening: Guidelines in 2021

Abstract : For many years, genetic screening for male infertility was limited to a few analyses: karyotyping, screening for Y microdeletions, and tests for the most frequent cystic fibrosis transmembrane conductance regulator (CFTR) gene variants. The development of new technologies, such as chromosome microarray or new genome sequencing, has broadened access to wholegenome analyses. Over the last decade, many genetic defects have been described, and new strategies seem to emerge. Hence, by focusing on peripheral (rather than central) failures of spermatogenesis, the objectives of the present study were to review the latest data on clinical practice (rather than the physiopathology of these genetic abnormalities) and suggest new guidelines for the genetic screening of male infertility.
Document type :
Journal articles
Complete list of metadata
Contributor : Inrae Breed <>
Submitted on : Monday, April 19, 2021 - 4:11:37 PM
Last modification on : Thursday, May 27, 2021 - 3:18:04 PM


Distributed under a Creative Commons Attribution 4.0 International License




Ghieh Farah, Béatrice Mandon-Pepin, Vialard François. Male Infertility and Genetic screening: Guidelines in 2021. Archives of Clinical and Biomedical Research, 2020, 05 (01), ⟨10.26502/acbr.50170151⟩. ⟨hal-03202224⟩



Record views